An Autopsy Case of an Elderly Patient with Classic Hodgkin Lymphoma Presenting with a Plethora of Clinical Symptoms and Signs.
Journal
The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566
Informations de publication
Date de publication:
22 Oct 2020
22 Oct 2020
Historique:
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
15
5
2021
Statut:
epublish
Résumé
BACKGROUND Hodgkin lymphoma (HL) is a potentially curable disease with favorable outcomes. However, elderly patients with HL usually have more adverse prognostic factors and hence a much worse prognosis than younger patients. CASE REPORT The patient was a woman in her 80s. She reported high fever, anorexia, and a weight loss of 8 kg within 5 months. She had been on treatment for diabetes mellitus and hypertension. She had undergone percutaneous coronary intervention and pacemaker implantation to treat acute coronary syndrome and sinus arrhythmia, respectively. Blood tests showed elevation of alkaline phosphatase, C-reactive protein, leukocyte count, CA 19-9, and carcinoembryonic antigen. Computed tomography did not show tumors in the liver, and cholangitis and sepsis were suspected. Aspartate transaminase, alanine aminotransferase, and total bilirubin gradually increased through the course of the patient's hospital stay. Despite treatment, her condition deteriorated and she died 22 days after hospital admission. At autopsy, we found stage IV HL with lymph node swelling on both sides of the diaphragm, as well as diffusely disseminated nodules in the liver and spleen. CONCLUSIONS Our patient had several poor prognostic factors including B symptoms, comorbidity, advanced stage, Epstein-Barr virus infection, and expression of programmed death-ligand 1 and interleukin-6, all of which were closely connected with her advanced age. Her age and comorbidities may have been the most adverse prognostic factors for her illness. An effective HL screening method for elderly individuals should be developed to ameliorate poor prognosis and adverse outcomes.
Identifiants
pubmed: 33087692
pii: 926177
doi: 10.12659/AJCR.926177
pmc: PMC7588351
doi:
Substances chimiques
Alanine Transaminase
EC 2.6.1.2
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e926177Références
Int J Hematol. 2016 Aug;104(2):236-44
pubmed: 27086350
J Clin Oncol. 2012 Sep 20;30(27):3383-8
pubmed: 22869887
Clin Lymphoma Myeloma. 2006 Jul;7(1):77-82
pubmed: 16879775
Blood. 2012 Oct 18;120(16):3280-7
pubmed: 22948049
BMC Res Notes. 2014 Aug 14;7:529
pubmed: 25125318
Front Oncol. 2019 Feb 25;9:104
pubmed: 30859093
Radiographics. 2001 Jan-Feb;21(1):161-79
pubmed: 11158651
Haematologica. 2011 Feb;96(2):269-76
pubmed: 21071500
Gut. 1961 Mar;2:60-71
pubmed: 13761549
Cancer Sci. 2010 Oct;101(10):2087-92
pubmed: 20624164
Eur J Cancer. 2005 May;41(7):1051-7
pubmed: 15862755
J Biol Chem. 2003 Nov 14;278(46):45777-84
pubmed: 12952969
Oncology (Williston Park). 2008 Nov 15;22(12):1369-79
pubmed: 19086599
Blood. 2017 Nov 30;130(22):2420-2430
pubmed: 28893733
Molecules. 2019 Mar 12;24(5):
pubmed: 30871092
Cell Mol Life Sci. 2020 Nov;77(21):4315-4324
pubmed: 32367191
Hepatology. 1993 Nov;18(5):1127-31
pubmed: 8225218
Blood. 2018 Apr 12;131(15):1654-1665
pubmed: 29500175
Leuk Lymphoma. 2013 Nov;54(11):2418-25
pubmed: 23432688
Diabetologia. 2002 Jun;45(6):805-12
pubmed: 12107724
J Clin Oncol. 2011 Oct 10;29(29):3914-20
pubmed: 21911729
Blood. 2008 Mar 15;111(6):3220-4
pubmed: 18203952
Br J Haematol. 2019 Jan;184(1):82-92
pubmed: 30407626
Leuk Lymphoma. 2010 Dec;51(12):2198-207
pubmed: 21054151
Clin Cancer Res. 2013 Dec 15;19(24):6812-9
pubmed: 24141626
Mediterr J Hematol Infect Dis. 2014 Jul 05;6(1):e2014053
pubmed: 25045461
Br J Cancer. 1993 Jan;67(1):185-9
pubmed: 8427778
Blood Adv. 2017 Aug 08;1(18):1427-1439
pubmed: 29296784
Br J Cancer. 2015 Nov 3;113(9):1375-80
pubmed: 26461060
Hematol Oncol. 2020 Apr;38(2):153-161
pubmed: 31953864
Endocr J. 2005 Apr;52(2):193-8
pubmed: 15863947
Pathology. 2020 Jan;52(1):154-165
pubmed: 31699300
Clin Cancer Res. 2013 Jul 1;19(13):3462-73
pubmed: 23674495
Cancer. 1989 Nov 15;64(10):2121-6
pubmed: 2804900
Cytokine. 2012 Jan;57(1):136-42
pubmed: 22035595
Crit Care. 2012 Dec 12;16(2):R58
pubmed: 22494810
Blood. 2005 Oct 1;106(7):2444-51
pubmed: 15941916
Pathol Int. 2019 Jul;69(7):407-413
pubmed: 31215109
Med Sci Law. 2012 Jul;52(3):174-7
pubmed: 22438507
Clin Lymphoma Myeloma. 2009 Jun;9(3):206-16
pubmed: 19525189
Pathobiology. 2010;77(6):301-8
pubmed: 21266828
Eur J Haematol. 2018 Jul;101(1):106-114
pubmed: 29727497
Indian J Pediatr. 2019 Jun;86(6):551-554
pubmed: 30830568
Surg Clin North Am. 2015 Oct;95(5):953-66
pubmed: 26315516
PLoS One. 2018 Sep 27;13(9):e0204870
pubmed: 30261066
Mediterr J Hematol Infect Dis. 2014 Jul 01;6(1):e2014050
pubmed: 25045458
N Engl J Med. 2010 Mar 11;362(10):875-85
pubmed: 20220182
Lab Med. 2017 Dec 22;49(1):80-86
pubmed: 29165611
Lancet. 2012 Sep 1;380(9844):836-47
pubmed: 22835602
Br J Haematol. 2002 Jul;118(1):195-201
pubmed: 12100148